Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea
- 10 June 2012
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 44 (10) , 788-792
Abstract
Background: Occult hepatitis B infection (OBI) is the presence of hepatitis B virus (HBV) DNA in serum or hepatic tissue without detectable hepatitis B surface antigen (HBsAg) in serum. Kidney disease patients in the post-renal transplantation period are in a specific situation as a result of the high pre-transplantational risk of HBV infection and post-transplantational immunosuppression. We studied the pre-transplantational prevalence and post-transplantational influence of OBI on kidney transplantation patients. Methods: We investigated pre-transplantational serum samples of 217 HBsAg-negative patients of post-renal transplant status for the presence of HBV DNA by real-time quantitative polymerase chain reaction. Serologic markers for HBV and hepatitis C virus (HCV) infection as well as liver enzymes were analyzed. Results: We detected HBV DNA in 2.3% (5/217) of HBsAg-negative patients, and the median HBV DNA titer was 33.15 copies/ml (range 30.6–144.6 copies/ml). Among the 5 OBI patients, 2 had hepatitis B surface antibodies (anti-HBs) and 1 had hepatitis B core antibodies (anti-HBc IgG). None of the patients with OBI were co-infected with HCV. There was no evidence of reactivation of OBI during the 36-month (range 27–63 months) follow-up monitoring period after transplantation, in spite of immune suppression to prevent rejection. Conclusions: The prevalence of occult HBV in the setting of renal transplantation was higher than that in the general population of Korea, and no reactivation of hepatitis B was observed in patients with OBI in the post-renal transplantation period.Keywords
This publication has 19 references indexed in Scilit:
- Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donorsTransfusion, 2011
- Management of occult hepatitis B virus infection: An update for the clinicianWorld Journal of Gastroenterology, 2011
- Clinical significance of occult hepatitis B virus infectionWorld Journal of Gastroenterology, 2011
- Occult Hepatitis B: Clinical Implications and Treatment DecisionsDigestive Diseases and Sciences, 2010
- Prevalence of occult hepatitis B virus infection in haemodialysis patients from central GreeceWorld Journal of Gastroenterology, 2010
- Prevalence of Occult Hepatitis B Virus Infection in a General Adult Population in KoreaIntervirology, 2009
- Changes of Hepatitis B Surface Antigen Seroprevalence in Korea, 1998-2005.Korean Journal of Epidemiology, 2008
- Occult hepatitis B virus in liver tissue of individuals without hepatic diseaseJournal of Hepatology, 2008
- Hepatitis B Virus DNA in Sera of Blood Donors and of Patients Infected with Hepatitis C Virus and Human Immunodeficiency VirusClinical and Vaccine Immunology, 2003
- Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.Journal of Clinical Pathology, 1993